| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $83M | ||
| $63M |
Buys | $0 | 0 | 0 |
Sells | $214,289 | 1 | 100 |
| BARRY JAMES | EVP, President, LSG | 0 | $0 | 1 | $214,289 | $-214,289 |
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Over the last 12 months, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $214,289 worth of Bio-Rad Laboratories, Inc. stock.
On average, over the past 5 years, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $3.78M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500 shares for transaction amount of $109,792 was made by HINCKLEY GREGORY K (director) on 2017‑05‑26.
| 2025-11-06 | Sale | BARRY JAMES | EVP, President, LSG | 699.87 0.0025% | $306.18 | $214,289 | -1.98% | |
| 2023-12-12 | Sale | WRIGHT DARA | EVP, President, CDG | 1,200 0.0042% | $299.16 | $358,992 | +10.06% | |
| 2023-11-28 | Sale | Crowley Michael | EVP, GBL Commercial Operations | 642 0.0022% | $305.10 | $195,874 | +5.43% | |
| 2023-08-30 | Sale | ERNST TIMOTHY S | EVP, General Counsel & Sec | 2,350 0.0081% | $395.60 | $929,667 | -20.36% | |
| 2023-08-23 | Sale | ERNST TIMOTHY S | EVP, General Counsel & Sec | 300 0.001% | $384.69 | $115,407 | -18.08% | |
| 2023-06-15 | Sale | Crowley Michael | EVP, GBL Commercial Operations | 500 0.0017% | $379.39 | $189,695 | -13.91% | |
| 2023-06-06 | Sale | RAMALINGAM AJIT | SVP, Chief Accounting Officer | 198.35 0.0007% | $368.30 | $73,053 | -11.27% | |
| 2023-03-08 | Sale | ERNST TIMOTHY S | EVP, General Counsel & Sec | 1,746 0.006% | $486.43 | $849,300 | -24.16% | |
| 2022-11-10 | Sale | RAMALINGAM AJIT | SVP, Chief Accounting Officer | 379.38 0.0013% | $421.87 | $160,051 | -6.40% | |
| 2022-08-05 | Sale | RAMALINGAM AJIT | SVP, Chief Accounting Officer | 518 0.0017% | $537.00 | $278,166 | -21.19% | |
| 2021-11-12 | Sale | TUMOLO ANNETTE | Executive Vice President | 4,800 0.016% | $750.05 | $3.6M | -29.26% | |
| 2021-11-11 | Sale | TUMOLO ANNETTE | Executive Vice President | 1,546 0.0052% | $749.00 | $1.16M | -28.86% | |
| 2021-09-03 | Sale | Daskal Ilan | EVP, Chief Financial Officer | 270 0.0009% | $820.06 | $221,416 | -28.93% | |
| 2021-09-02 | Sale | Daskal Ilan | EVP, Chief Financial Officer | 540 0.0018% | $828.00 | $447,121 | -29.43% | |
| 2021-09-01 | Sale | Last Andrew J. | EVP, Chief Operating Officer | 2,000 0.0067% | $813.10 | $1.63M | -28.42% | |
| 2021-08-26 | Sale | TUMOLO ANNETTE | Executive Vice President | 600 0.002% | $792.58 | $475,548 | -26.32% | |
| 2021-08-09 | Sale | Crowley Michael | EVP, GBL Commercial Operations | 3,000 0.01% | $754.93 | $2.26M | -19.26% | |
| 2021-08-04 | Sale | ERNST TIMOTHY S | EVP, General Counsel & Sec | 327 0.0011% | $760.26 | $248,605 | -19.02% | |
| 2021-08-04 | Sale | Daskal Ilan | EVP, Chief Financial Officer | 2,300 0.0076% | $751.84 | $1.73M | -19.02% | |
| 2021-02-19 | Sale | ERNST TIMOTHY S | EVP, General Counsel & Sec | 923.11 0.0021% | $432.07 | $398,851 | +4.93% |
| BARRY JAMES | EVP, President, LSG | 510 0.0019% | $141,436.76 | 0 | 1 | |
| SCHWARTZ ALICE N | director, 10 percent owner | 1806651 6.6936% | $501.35M | 1 | 2 | <0.0001% |
| SCHWARTZ NORMAN D | Chairman, President, and CEO | 411252 1.5237% | $114.12M | 0 | 3 | |
| GOETZ JOHN | EVP, Chief Operating Officer | 61174 0.2267% | $16.98M | 0 | 9 | |
| BENNETT JAMES | director | 32546 0.1206% | $9.03M | 0 | 3 | |
| Magni Giovanni | EVP, Chief Strategy Officer | 20738 0.0768% | $5.75M | 0 | 26 | |
| HERTIA JOHN | Executive Vice President | 18728 0.0694% | $5.2M | 0 | 11 | |
| WADLER SANFORD | VP, General Counsel, Secretary | 11936 0.0442% | $3.31M | 0 | 20 | |
| SCHWARTZ DAVID | Chairman of the Board | 8753 0.0324% | $2.43M | 1 | 0 | <0.0001% |
| Crowley Michael | EVP, GBL Commercial Operations | 6942 0.0257% | $1.93M | 0 | 21 | |
| TSINGOS CHRISTINE A | EVP and CFO | 6683 0.0248% | $1.85M | 0 | 22 | |
| HILLMAN AL | director | 6252 0.0232% | $1.73M | 0 | 1 | |
| CRUTCHFIELD BRADFORD | Executive Vice President | 6023 0.0223% | $1.67M | 0 | 11 | |
| TUMOLO ANNETTE | Executive Vice President | 4593 0.017% | $1.27M | 0 | 7 | |
| HUTTON RONALD W | Vice President and Treasurer | 4140 0.0153% | $1.15M | 1 | 17 | <0.0001% |
| ERNST TIMOTHY S | EVP, General Counsel & Sec | 2416 0.009% | $670,383.53 | 0 | 9 | |
| SCHWARTZ STEVEN D | 10 percent owner | 1818 0.0067% | $504,504.30 | 0 | 4 | |
| WRIGHT DARA | EVP, President, CDG | 1499 0.0056% | $415,994.03 | 0 | 1 | |
| Last Andrew J. | EVP, Chief Operating Officer | 1282 0.0047% | $355,732.27 | 0 | 1 | |
| SODERBERG SHAWN MARIE | EVP, General Counsel, Sec | 652 0.0024% | $180,962.30 | 0 | 5 | |
| Hall Shannon | Executive Vice President | 565 0.0021% | $156,667.93 | 0 | 9 | |
| HINCKLEY GREGORY K | director | 500 0.0019% | $138,750.00 | 1 | 0 | +11% |
| STARK JAMES R | VP, Corporate Controller | 0 0% | $0 | 1 | 27 | <0.0001% |
| Daskal Ilan | EVP, Chief Financial Officer | 9 0% | $2,497.50 | 0 | 3 | |
| RAMALINGAM AJIT | SVP, Chief Accounting Officer | 0 0% | $0 | 0 | 3 |
| Increased Positions | 167 | +33.81% | 1M | +7.43% |
| Decreased Positions | 204 | -41.3% | 2M | -8.1% |
| New Positions | 58 | New | 425,847 | New |
| Sold Out Positions | 55 | Sold Out | 365,145 | Sold Out |
| Total Postitions | 457 | -7.49% | 19M | -0.67% |
| First Eagle Investment Management, Llc | $769,378.00 | 11.46% | 2.52M | +3,006 | +0.12% | 2025-09-30 |
| Vanguard Group Inc | $547,513.00 | 8.15% | 1.79M | -53,006 | -2.87% | 2025-09-30 |
| Blackrock, Inc. | $517,692.00 | 7.71% | 1.7M | -66,810 | -3.79% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $324,483.00 | 4.83% | 1.06M | +63,370 | +6.34% | 2025-09-30 |
| Veritas Asset Management Llp | $257,660.00 | 3.84% | 844,039 | -19,102 | -2.21% | 2025-09-30 |
| Ariel Investments, Llc | $247,110.00 | 3.68% | 809,480 | -9,144 | -1.12% | 2025-09-30 |
| Earnest Partners Llc | $185,996.00 | 2.77% | 609,284 | +3,398 | +0.56% | 2025-09-30 |
| State Street Corp | $174,492.00 | 2.6% | 571,599 | -12,767 | -2.19% | 2025-09-30 |
| Bank Of America Corp /De/ | $140,390.00 | 2.09% | 459,887 | +7,754 | +1.72% | 2025-09-30 |
| Capital Research Global Investors | $127,711.00 | 1.9% | 418,355 | +418,355 | New | 2025-09-30 |